1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc.

CLDI
Calidi Biotherapeutics, Inc.US flagNew York Stock Exchange American
0.10
USD
-0.02
- -
733,016.00Market Cap

Income Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- Operating Expenses
7
11
23
26
22
20
+ Selling, General & Admin
4
6
16
16
13
11
+ Research & Development
3
5
7
13
9
10
+ Other Operating Expense
- -
- -
- -
-3
- -
- -
Operating Income (Loss)
-7
-10
-23
-26
-22
-20
- Non-Operating (Income) Loss
1
- -
2
3
1
- -
+ Interest Expense, Net
- -
1
- -
1
1
- -
+ Interest Expense
- -
1
- -
1
1
- -
- Interest Income
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
1
- -
2
2
- -
- -
Pretax Income
-8
-11
-25
-29
-22
-20
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-8
-11
-25
-29
-22
-20
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-8
-11
-25
-29
-22
-20
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-8
-11
-25
-29
-22
-20
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-8
-11
-25
-29
-22
-20
EBIT
-7
-10
-23
-26
-22
-20
EBITDA
-7
-10
-23
-25
-20
-19
EBITDA Margin (%)
- -
-2,300.45
-50,833.33
- -
- -
- -
EBITA
-7
-10
-23
-26
-22
-20
Gross Margin (%)
- -
79.06
68.89
- -
- -
- -
Operating Margin (%)
- -
-2,334.52
-51,395.56
- -
- -
- -
Profit Margin (%)
- -
-2,434.97
-56,504.44
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
2
2
Basic Weighted Avg Shares
- -
- -
- -
- -
1
4
Basic EPS, GAAP
-26.53
-36.54
-84.98
-207.94
-33.2
-4.63
Basic EPS from Cont Ops
-26.53
-36.54
-84.98
-207.94
-33.3
-4.66
Diluted Weighted Avg Shares
- -
- -
- -
- -
1
4
Diluted EPS, GAAP
-26.53
-36.54
-84.98
-207.94
-33.2
-4.63
Diluted EPS from Cont Ops
-26.53
-36.54
-84.98
-207.94
-33.3
-4.66

Balance Sheet (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
1
3
1
4
10
6
+ Cash, Cash Equivalents & STI
- -
2
- -
2
10
6
+ Cash & Cash Equivalents
- -
2
- -
2
10
6
+ ST Investments
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
1
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
1
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
- -
1
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
1
2
6
4
3
+ Property, Plant & Equip, Net
1
1
1
5
4
2
+ Property, Plant & Equip
1
1
2
6
5
4
- Accumulated Depreciation
- -
- -
1
1
1
2
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
1
- -
1
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
1
- -
1
- -
- -
- -
Total Assets
2
3
3
10
14
9
+ Payables & Accruals
3
4
8
8
5
2
+ Accounts Payable
1
1
2
3
2
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
4
5
6
3
2
+ ST Debt
5
5
6
2
4
2
+ ST Borrowings
5
5
5
1
3
- -
+ ST Finance Leases
- -
- -
- -
1
1
2
+ Other ST Liabilities
1
17
30
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
17
30
- -
- -
- -
Total Current Liabilities
9
26
43
10
9
4
+ LT Debt
6
- -
- -
5
3
1
+ LT Borrowings
6
- -
- -
2
1
1
+ LT Finance Leases
- -
- -
- -
3
2
- -
+ Other LT Liabilities
9
9
10
3
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
9
9
10
3
- -
- -
Total Noncurrent Liabilities
15
9
10
8
3
1
Total Liabilities
24
35
53
18
12
5
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
12
13
20
91
123
145
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
12
13
20
91
123
145
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-34
-45
-70
-100
-122
-142
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-22
-32
-50
-8
2
4
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
-22
-32
-50
-8
2
4
Total Liabilities & Equity
2
3
3
10
14
9
Shares Outstanding
- -
- -
- -
- -
2
7
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
1
4
3
2
Net Debt
11
3
5
1
-6
-5
Net Debt to Equity
-48.46
-9.06
-10.02
-11.15
-295.48
-133.01
Tangible Common Equity Ratio
-1,213.82
-932.23
-1,942.24
-82.19
13.88
42.44
Current Ratio
0.06
0.11
0.02
0.42
1.08
1.59
Cash Conversion Cycle
- -
-2,586.06
-34,336.07
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-8
-11
-25
-29
-22
-20
+ Depreciation & Amortization
- -
- -
- -
1
2
2
+ Non-Cash Items
2
2
8
7
3
2
+ Stock-Based Compensation
1
1
6
5
3
2
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
1
1
2
2
- -
- -
+ Chg in Non-Cash Work Cap
1
1
4
-6
-2
-5
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
-2
2
- -
+ Inc (Dec) in Accts Payable
1
2
3
-5
-2
-3
+ Inc (Dec) in Other
- -
- -
- -
1
-1
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-5
-8
-13
-27
-20
-21
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
-1
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
-1
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
3
- -
- -
3
18
17
+ Increase in Capital Stock
3
- -
- -
3
18
17
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
2
2
1
1
2
-2
+ Cash From Debt
2
2
2
3
4
- -
+ Repayments of Debt
- -
- -
- -
-3
-2
-2
+ Other Financing Activities
- -
8
11
26
7
3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
5
10
12
29
27
17
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-1
2
-2
2
8
-4
EBITDA
-7
-10
-23
-25
-20
-19
EBITDA Margin (%)
- -
-2,300.45
-50,833.33
- -
- -
- -
Free Cash Flow
-5
-8
-14
-28
-20
-21
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-6
-12
-27
-18
-24
Free Cash Flow per Basic Share
-17.3
-26.67
-45.59
-196.21
-29.55
-4.98
Price/Free Cash Flow
- -
-46.54
-28.56
-0.96
-0.47
-0.24
Cash Flow to Net Income
0.61
0.71
0.52
0.92
0.89
1.07
Capital Expenditures
- -
- -
- -
-1
- -
- -